The invention relates to thiadiazole compounds useful for treating diseases mediated by protein kinase B (PKB). The invention also relates to the therapeutic use of such thiadiazole compounds and compositions thereof in treating disease states associated with abnormal cell growth, cancer, inflammation, and metabolic disorders.

 
Web www.patentalert.com

< Thermally insulated apparatus for liquid chromatographic analysis

< Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

> Compositions of pegylated soluble tumor necrosis factor receptors and methods of preparing

> Peptides and related molecules that bind to TALL-1
~ 00600